A group of Duke chemists are in the process of refining a new diversity-based method to serve as a starting point for drug discovery and research.
Approximately 8.2 million Americans and 60,000 North Carolinians suffer from Type 2 diabetes, a metabolic disorder involving insulin irregularities and high blood glucose levels.
This is the second in a three-part series about health and science issues in the 2004 election.
This is the last in a four-part series about the Institute for Genome Sciences and Policy.
This is the third in a four-part series about the Institute for Genome Sciences and Policy.
This is the second in a four-part series about the Institute for Genome Sciences and Policy.
This is the first in a four-part series about the Institute for Genome Sciences and Policy.
To Alan Rosenkranz, a Florida native, it was a miracle that he could take his 8-year-old granddaughter on a trip to New York City this past summer.
Eleven of the world�s top medical journals are making the reporting of all clinical trial results a condition of publication in an attempt to remedy concerns about the selective disclosure...
In an effort to address some of the most pressing ethical, legal and social questions that have developed along with recent advances in genetic and genome science, the National Human Genome...
